Yumanity, the J. Craig Venter Institute, and dozens of other companies around the biotech industry received Paycheck Protection Program loans, according to data disclosed Monday.

The J. Craig Venter Institute got a more than $2 million loan that covered more than 150 employees. Neurodegeneration-focused startup Yumanity Therapeutics received more than $1 million through the program. LabCentral, a Cambridge, Mass., incubator, received about $720,000 from the program. And the American Association of Cancer Research, which held its annual convention virtually this year, received enough from the program to pay more than 200 people.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • No fair for big rich companies to get that money which was to help only small business stay in business.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy